Purchase Order 75F40121P00369
- Not listed
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Sony Biotechnology Inc., a specialized manufacturer and provider of flow cytometry and imaging instrumentation, reagents, and services to support biomedical research for federal agencies. The contract, valued at $487,282.36, is for the provision of a cell sorter and spectral analyzer system. The contract does not have a set-aside designation, reflecting the specialized nature of the products...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Sony Biotechnology Inc., a for-profit manufacturer, for the delivery of a Sony MA900 multi-parameter cell sorter. The cell sorter will support future DCGT projects and collaborations within FDA to identity and characterize gene and cell therapy products. The potential value of the award is $224,880.80. This is an open competition solicitation and does not include any...
- Sony Biotechnology Inc., doing business as Sony Corp of America, was awarded a firm fixed-price purchase order valued at $290,578.60 by the Pacific West Area, a civilian federal agency, on August 16, 2023, with an ultimate completion date of November 14, 2023. The contract covers the procurement of a Sony MA900 cell sorter equipped with 488 nanometer, 638 nanometer, and 405 nanometer lasers. This award carries no set-aside designation and will be performed in Japan, the manufacturer's home...
- This is a $152,280.00 firm-fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health under the Department of Health and Human Services, to Sony Biotechnology Inc. for preventive maintenance services on a single Sony MA900 cell sorter. The contract has a period of performance through June 30, 2029. Sony Biotechnology is a for-profit manufacturer that provides flow cytometry and imaging instrumentation, reagents, and services...
- This firm-fixed-price purchase order contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sony Biotechnology Inc. for preventive maintenance services on one (1) Sony LE-SA800 cell sorter. The contract has a ceiling value of $119,475.00 and a completion date of April 12, 2028. Sony Biotechnology Inc. is a specialized manufacturer and provider of flow cytometry and imaging instrumentation, reagents, and services to...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences has awarded a firm-fixed-price purchase order to Sony Biotechnology Inc., a for-profit manufacturer, to provide a maintenance/service agreement for the Sony SH800 cell sorter. The contract has a potential value of $105,280.00 and a completion date of May 31, 2028. The contract does not have a set-aside designation. Through this award, Sony Biotechnology will ensure...
- Sony Biotechnology Inc., operating as Sony Corp of America, was awarded a firm fixed-price purchase order by the Centers for Disease Control and Prevention (CDC) Pittsburgh on January 18, 2024, for Sony cell sorter service. The contract has a ceiling value of $123,457.50 with an ultimate completion date of January 20, 2029, and no set-aside designation was utilized. The place of performance is Atlanta, Georgia. As a specialized manufacturer of advanced flow cytometry and cell sorting...
- The National Heart Lung and Blood Institute awarded a firm fixed-price purchase order to Sony Biotechnology Inc. on May 20, 2021, for Sony SH800 Flow Cytometer system maintenance services. The contract, valued at $158,025.22 with a completion date of May 19, 2026, was awarded without a set-aside designation. Sony Biotechnology Inc., based in San Jose, California, will perform the maintenance work at its California facility. The rapid award timeline—with the solicitation posted on May 13, 2021,...
- This is a $17,200 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) to Sony Biotechnology Inc., a specialized manufacturer of flow cytometry and imaging instrumentation, reagents, and services. The contract does not utilize a set-aside designation. The award supports the delivery, installation, and ongoing maintenance of Sony's specialized cell sorting and analysis equipment, including MA900 cell sorters, SH800 cell sorters, and ID7000 spectral cell analyzers....
- This is a $89,052 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Sony Biotechnology Inc. for a maintenance agreement. The contract does not utilize any set-aside designations. Sony Biotechnology Inc. is a specialized manufacturer and provider of flow cytometry and imaging instrumentation, reagents, and services to support biomedical research for federal agencies. This contract likely...
The Food and Drug Administration awarded a $105,462 firm fixed-price purchase order to Sony Biotechnology Inc. for preventive maintenance and service support on cell sorter and cell spectral analyzer equipment. The contract, which was awarded on July 22, 2021, with an ultimate completion date of September 2, 2025, covers ongoing maintenance services for advanced flow cytometry and imaging instrumentation located at the FDA's San Jose, California facility. No small business set-aside was utilized for this procurement. Sony Biotechnology Inc., a specialized manufacturer of cutting-edge cell sorting and analysis technologies based in San Jose, is well-positioned to provide this support given its focus on sophisticated scientific equipment and maintenance services for federal research agencies. This award reflects Sony Biotechnology's established track record in providing maintenance and support services for advanced laboratory instrumentation to federal agencies. The company has a substantial history of supplying and maintaining cell sorting and imaging equipment such as cell sorters and spectral flow cytometers to National Institutes of Health entities and other Department of Health and Human Services components. The preventive maintenance contract with the FDA supports the agency's laboratory operations and research capabilities, ensuring optimal performance and availability of critical analytical equipment used in the agency's regulatory and scientific programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Close Out | $0 | 3/12/26 | |
| P00005 | Other Administrative Action | $0 | 9/2/25 | |
| P00004 | Exercise an Option | $34.4k | 6/12/23 | |
| P00003 | Exercise an Option | $35.2k | 8/31/22 | |
| P00002 | Other Administrative Action | $0 | 5/20/22 |